159 related articles for article (PubMed ID: 20473744)
1. Research on the mechanism of Zuogui Pill and Yougui Pill in promoting axonal regeneration in model rats of autoimmune encephalomyelitis.
Wang L; Zhao H; Fan YP; Gong HY; Li M; Qi F; Liu Y
Chin J Integr Med; 2010 Apr; 16(2):167-72. PubMed ID: 20473744
[TBL] [Abstract][Full Text] [Related]
2. Effects of Zuogui Pill () and Yougui Pill () on the expression of brain-derived neurotrophic factor and cyclic adenosine monophosphate/protein kinase A signaling transduction pathways of axonal regeneration in model rats with experimental autoimmune encephalomyelitis.
Wang YZ; Kou S; Gu LY; Zheng Q; Li M; Qi F; Zhao H; Wang L
Chin J Integr Med; 2014 Jan; 20(1):24-30. PubMed ID: 23212569
[TBL] [Abstract][Full Text] [Related]
3. Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis.
Kou S; Zheng Q; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Fang L; Liu L; Ouyang J; Zhao H; Wang L
J Ethnopharmacol; 2014 Dec; 158 Pt A():102-12. PubMed ID: 25448504
[TBL] [Abstract][Full Text] [Related]
4. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the Yougui pill in experimental autoimmune encephalomyelitis model rats and its pharmacological activity in vitro.
Liu H; Qiu F; Yang X; Zhao H; Bian B; Wang L
Drug Des Devel Ther; 2019; 13():2357-2370. PubMed ID: 31409970
[TBL] [Abstract][Full Text] [Related]
6. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Fan Y; Yang T; Zheng Q; Wang L; Yuan C; Fang L; Li K
J Tradit Chin Med; 2014 Oct; 34(5):576-83. PubMed ID: 25417409
[TBL] [Abstract][Full Text] [Related]
8. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral mediated expression of a NGF-soluble Nogo receptor 1 fusion protein promotes axonal regeneration.
Zhang Y; Gao F; Wu D; Moshayedi P; Zhang X; Ellamushi H; Yeh J; Priestley JV; Bo X
Neurobiol Dis; 2013 Oct; 58():270-80. PubMed ID: 23811498
[TBL] [Abstract][Full Text] [Related]
10. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
Peng X; Zhou Z; Hu J; Fink DJ; Mata M
J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis.
Fang L; Wang Y; Zheng Q; Yang T; Zhao P; Zhao H; Zhang Q; Zhao Y; Qi F; Li K; Chen Z; Li J; Zhang N; Fan Y; Wang L
BMC Complement Altern Med; 2017 Jul; 17(1):346. PubMed ID: 28668079
[TBL] [Abstract][Full Text] [Related]
12. Time course and spatial profile of Nogo-A expression in experimental autoimmune encephalomyelitis in C57BL/6 mice.
Theotokis P; Lourbopoulos A; Touloumi O; Lagoudaki R; Kofidou E; Nousiopoulou E; Poulatsidou KN; Kesidou E; Tascos N; Spandou E; Grigoriadis N
J Neuropathol Exp Neurol; 2012 Oct; 71(10):907-20. PubMed ID: 22964785
[TBL] [Abstract][Full Text] [Related]
13. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant adeno-associated virus conducted NgR(DN) enhances axonal regeneration of optic nerve after trauma: experiment with rats].
Wang F; Wang JQ; Su Y; Shan YC; Zhao SG; Teng Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2856-60. PubMed ID: 18167294
[TBL] [Abstract][Full Text] [Related]
15. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
16. Silencing Nogo-A promotes functional recovery in demyelinating disease.
Yang Y; Liu Y; Wei P; Peng H; Winger R; Hussain RZ; Ben LH; Cravens PD; Gocke AR; Puttaparthi K; Racke MK; McTigue DM; Lovett-Racke AE
Ann Neurol; 2010 Apr; 67(4):498-507. PubMed ID: 20437585
[TBL] [Abstract][Full Text] [Related]
17. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
19. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
20. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
